FDA Approved Products

4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Active:Lifecycle: LOE ApproachingClear all
METROGEL
metronidazole
LOE Approaching
Galderma
TOPICAL · GEL
2005
SMNDA
30/100
METROGEL-VAGINAL
metronidazole
LOE Approaching
Bausch + Lomb
VAGINAL · GEL
the treatment of bacterial vaginosis (formerly referred toGardnerella vaginitis+3
1992
SMNDA
30/100
METROLOTION
metronidazole
LOE Approaching
Galderma
TOPICAL · LOTION
1998
SMNDA
30/100
METRONIDAZOLE
metronidazole
LOE Approaching
Molecular Devices
ORAL · TABLET
1983
SMNDA
30/100
METRONIDAZOLE
metronidazole
LOE Approaching
Teva
ORAL · TABLET
1981
SMNDA
30/100
METRONIDAZOLE
metronidazole
LOE Approaching
ORAL · TABLET
1983
SMNDA
30/100
METRONIDAZOLE
metronidazole
LOE Approaching
ORAL · TABLET
1984
SMNDA
30/100
METRONIDAZOLE
metronidazole
LOE Approaching
Hikma
INJECTION · INJECTABLE
1984
SMNDA
30/100
METRONIDAZOLE
metronidazole
LOE Approaching
Teva
ORAL · TABLET
1982
SMNDA
30/100
METRONIDAZOLE
metronidazole
LOE Approaching
Fosun Pharma
ORAL · TABLET
1982
SMNDA
30/100
METRONIDAZOLE
metronidazole
LOE Approaching
Fosun Pharma
ORAL · TABLET
1982
SMNDA
30/100
METRONIDAZOLE
metronidazole
LOE Approaching
Abbott
INJECTION · INJECTABLE
1983
SMNDA
30/100
METRONIDAZOLE
metronidazole
LOE Approaching
Molecular Devices
ORAL · TABLET
1983
SMNDA
30/100
METRONIDAZOLE IN PLASTIC CONTAINER
metronidazole
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1983
SMNDA
30/100
METUBINE IODIDE
metocurine iodide
LOE Approaching
Eli Lilly and Company
INJECTION · INJECTABLE
1949
NDA
30/100
METVIXIA
methyl aminolevulinate hydrochloride
LOE Approaching
Galderma
TOPICAL · CREAM
2004
NDA
30/100
MEVACOR
lovastatin
LOE Approaching
Merck & Co.
ORAL · TABLET
1987
SMNDA
30/100
MEXITIL
mexiletine hydrochloride
LOE Approaching
Boehringer Ingelheim
ORAL · CAPSULE
1985
NDA
30/100
MEZLIN
mezlocillin sodium monohydrate
LOE Approaching
R-Pharm US
INJECTION · INJECTABLE
1981
NDA
30/100
MIACALCIN
calcitonin salmon
LOE Approaching
Viatris (2)
INJECTION · INJECTABLE
symptomatic Paget's disease of bone in patients with moderate to severe disease characterized by polyostotic involvement with elevated serum alkaline phosphataseurinary hydroxyproline excretion+4
1986
NDA
30/100
MIACALCIN
calcitonin salmon
LOE Approaching
NASAL · SPRAY, METERED
1995
NDA
30/100
MICARDIS
telmisartan
LOE Approaching
Boehringer Ingelheim
ORAL · TABLET
1998
SMNDA
30/100
MICARDIS HCT
telmisartan and hydrochlorothiazide
LOE Approaching
Boehringer Ingelheim
ORAL · TABLET
2000
NDA
30/100
MICRO-K
potassium chloride
LOE Approaching
R-Pharm US
ORAL · CAPSULE, EXTENDED RELEASE
1980
NDA
30/100
← PreviousPage 99 of 188Next →